GENFIT (EPA:GNFT) | WebDisclosure

PRESS RELEASE

published on 06/10/2024 at 23:22, 1 year 7 months ago

GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine
GENFIT franchit une étape historique avec l'approbation accélérée d'Iqirvo par la FDA américaine pour la Cholangite Biliaire Primitive en partenariat avec Ipsen

Approbation Accélérée Cholangite Biliaire Primitive GENFIT Iqirvo FDA Américaine
PRESS RELEASE

published on 06/10/2024 at 23:22, 1 year 7 months ago

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
GENFIT achieves historic milestone with U.S. FDA accelerated approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis. Elafibranor tablets approved as first-in-class treatment, marking a significant development in rare liver disease treatment landscape

Primary Biliary Cholangitis GENFIT Ipsen Iqirvo FDA Accelerated Approval
BRIEF

published on 05/29/2024 at 22:15, 1 year 8 months ago

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024

Research Collaboration GENFIT ACLF EASL Congress Liver Disease
BRIEF

published on 05/29/2024 at 22:15, 1 year 8 months ago

GENFIT présentera ses dernières recherches sur l'ACLF au congrès EASL™ 2024

Collaboration En Recherche GENFIT ACLF Congrès De L'EASL Maladie Du Foie
PRESS RELEASE

published on 05/29/2024 at 22:10, 1 year 8 months ago

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
GENFIT to present latest ACLF research at EASL Congress™ 2024, showcasing collaborative efforts with EF CLIF to advance understanding of ACLF pathophysiology and treatment approaches

Liver Diseases GENFIT ACLF Research EASL Congress 2024 EF CLIF Partnership
PRESS RELEASE

published on 05/29/2024 at 22:10, 1 year 8 months ago

GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024
GENFIT présente ses avancées dans l'ACLF au congrès EASL 2024, détaillant un partenariat de recherche avec l'EF CLIF et des programmes de recherche dans l'ACLF, mettant en avant le potentiel de transformation du traitement

Recherche Traitement GENFIT ACLF EASL
BRIEF

published on 05/14/2024 at 22:15, 1 year 8 months ago

GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025

Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF

published on 05/14/2024 at 22:15, 1 year 8 months ago

GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025

Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
PRESS RELEASE

published on 05/14/2024 at 22:10, 1 year 8 months ago

GENFIT Reports First Quarter 2024 Financial Information
GENFIT reports Q1 2024 financial information showing cash position of €74.0 million and revenues of €1.1 million. Company expects cash to fund operations until Q4 2025

Financial Information Revenues Cash Position Q1 2024 GENFIT
PRESS RELEASE

published on 05/14/2024 at 22:10, 1 year 8 months ago

GENFIT : Information financière du premier trimestre 2024
GENFIT annonce sa situation de trésorerie au 31 mars 2024 et son chiffre d'affaires du premier trimestre 2024, avec des revenus en baisse par rapport à 2023

Chiffre D'affaires Biopharmaceutique Trésorerie Maladies Rares GENFIT

Published on 02/04/2026 at 18:00, 2 hours 27 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 4 hours 12 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 4 hours 42 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 5 hours 27 minutes ago

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 14:30, 5 hours 57 minutes ago

Datametrex Expands Business In Data Centres

View all ACCESSWIRE

Published on 02/04/2026 at 20:00, 27 minutes ago

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 1 hour 32 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 1 hour 47 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:34, 1 hour 53 minutes ago

E-PANGO: Composition du capital au 31 janvier 2026
Published on 02/04/2026 at 18:14, 2 hours 13 minutes ago

Issue of Equity

View all EQS

Published on 02/04/2026 at 18:04, 2 hours 23 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 2 hours 23 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 2 hours 42 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 2 hours 42 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 2 hours 42 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE

News